CJC1295 without DAC

CJC-1295 without DAC – Short-Acting GHRH Analogue Research Peptide

Short Description: CJC-1295 without DAC is a GHRH analogue studied for its ability to induce short-term, physiological GH release through pulsatile receptor activation in in-vitro settings.

CJC-1295 without DAC is a synthetic Growth Hormone–Releasing Hormone (GHRH) analogue designed to stimulate the release of growth hormone (GH) by binding to GHRH receptors. Unlike the DAC-modified version, this peptide exhibits a shorter half-life, enabling researchers to examine the natural, pulsatile secretion of growth hormone in in-vitro models.

This compound is manufactured under strict laboratory standards and verified through High-Performance Liquid Chromatography (HPLC) to ensure a purity of ≥99%. It is formulated as a stable lyophilized powder for use in biochemical and endocrinological research.

Key Specifications

• Name: CJC-1295 without DAC

• Molecular Formula: C152H252N44O42

• Molecular Weight: ≈ 3368.9 Da

• Form: Lyophilized Powder

• Purity: ≥99% (HPLC tested)

• Storage: Store refrigerated, protected from light and moisture

Research Applications & Benefits

• Used in research on physiological GH secretion patterns.

• Relevant to studies of growth hormone regulation and GHRH receptor dynamics.

• Allows modeling of natural pulsatile endocrine responses.

• Supplied in a format ideal for stable storage and repeatable experimental use.

For research use only. Not for human or veterinary consumption.